Skip to content

Cellebrite

US · CLBT #2562 by market cap Listed 1970
11.23 -0.15 -1.28%
Live - 5344 symbols - heartbeat 53s ago · 2026-10-08 06:56
Pre-market 11.00 -2.00%
After-hours 11.23 0.00%
Market cap
2.82B
P/B
5.24
EPS
0.31
Reader sentiment Are you bullish or bearish on CLBT?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
  • Total institutional ownership rose 0.4 percentage points.

Institutional ownership

Held by institutions
94.26% +0.36pp
Institutions
254 -2
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Public Company44.90%
Mutual Fund26.23%
Hedge Fund16.38%
VC/PE Fund5.68%
Individual/Insider1.70%
Government Pension Fund0.47%
Private Company0.36%
Other4.11%

Top holders as of 2025-12-31

Sun Corporation 42.29% · 106.07M sh
True Wind Capital Management, L.P. 5.53% · 13.86M sh
Voss Capital, LP 5.06% · 12.70M sh
Pertento Partners LLP 3.19% · 8.00M sh
Phoenix Investments & Finances Ltd 2.46% · 6.18M sh
FMR 2.30% · 5.77M sh
BlackRock 2.27% · 5.68M sh
Capital Research 1.66% · 4.17M sh
Nine Ten Capital Management, LLC 1.65% · 4.13M sh
Artisan Partners Limited Partnership 1.30% · 3.27M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 10 buys · 17 sells

NameRoleStake
Adam Clammer Independent External Director 0.33%
Thomas Hogan Executive Chairperson 0.31%
Christopher Wade Chief Technology Officer 0.24%
David Barter Chief Financial Officer 0.13%
Ronnen Armon Chief Products & Technologies Officer 0.11%
Zohar Tadmor-Eilat Chief Human Resources Officer 0.05%
Marcus Jewell Global Chief Revenue Officer 0.05%
Holly Windham Chief Compliance Officer 0.04%
Sigalit Shavit Chief Information Officer 0.03%
Yonatan Domnitz Independent Director 0.03%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-23 Shiven Ramji President of Products & Technology Other Acquisition +38,505 --
2026-09-16 Dafna Gruber Independent External Director Other Acquisition +15,190 --
2026-09-16 Adam Clammer Independent External Director Other Acquisition +15,190 --
2026-09-16 Troy Richardson Director Other Acquisition +15,190 --
2026-09-16 Brandon Van Buren Director Other Acquisition +15,190 --
2026-09-16 Nadine Baudot-Trajtenberg Independent External Director Other Acquisition +15,190 --
2026-09-16 Yonatan Domnitz Independent Director Other Acquisition +15,190 --
2026-09-16 Ryusuke Utsumi Independent Director Other Acquisition +15,190 --
2026-08-24 Thomas Hogan Executive Chairperson Open Market Disposition -25,299 $11.29
2026-08-23 David Gee Chief Marketing Officer Automatic Disposition -4,323 $11.36
2026-08-20 David Gee Chief Marketing Officer Open Market Disposition -2,198 $11.24
2026-08-20 Marcus Jewell Global Chief Revenue Officer Open Market Disposition -12,562 $11.24
2026-08-11 Thomas Hogan Executive Chairperson Open Market Disposition -139,713 $15.39
2026-08-11 David Gee Chief Marketing Officer Open Market Disposition -230 $16.07
2026-08-11 Marcus Jewell Global Chief Revenue Officer Open Market Disposition -411 $16.07
2026-08-10 Thomas Hogan Executive Chairperson Other Acquisition +339,484 --
2026-07-07 David Barter Chief Financial Officer Open Market Disposition -41,734 $16.38
2026-07-05 Ronnen Armon Chief Products & Technologies Officer Intent to Sell (Form 144) -29,330 $16.43
2026-07-01 Thomas Hogan Executive Chairperson Open Market Disposition -103,188 $15.76
2026-06-30 Ronnen Armon Chief Products & Technologies Officer Intent to Sell (Form 144) -43,983 $15.40

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 06:56:53 · For reference only, not investment advice and not tailored to your situation.